Sigachi Industries Limited (BOM:543389)
India · Delayed Price · Currency is INR 19.69
+2.69 (15.82%)
At close: Apr 1, 2026
Sigachi Industries Revenue
Sigachi Industries had revenue of 1.18B INR in the quarter ending December 31, 2025, a decrease of -16.80%. This brings the company's revenue in the last twelve months to 4.85B, up 0.33% year-over-year. In the fiscal year ending March 31, 2025, Sigachi Industries had annual revenue of 5.00B with 23.81% growth.
Revenue (ttm)
4.85B
Revenue Growth
+0.33%
P/S Ratio
1.52
Revenue / Employee
3.22M
Employees
1,507
Market Cap
7.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 5.00B | 962.25M | 23.81% |
| Mar 31, 2024 | 4.04B | 1.02B | 33.79% |
| Mar 31, 2023 | 3.02B | 517.55M | 20.68% |
| Mar 31, 2022 | 2.50B | 544.85M | 27.83% |
| Mar 31, 2021 | 1.96B | 530.96M | 37.21% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IOL Chemicals and Pharmaceuticals | 22.27B |
| Bajaj HealthCare | 6.12B |
| NGL Fine-Chem | 4.47B |
| Aarey Drugs & Pharmaceuticals | 3.91B |
| Anlon Healthcare | 1.70B |
| Gujarat Themis Biosyn | 1.59B |
| Influx Healthtech | 1.24B |
| Shree Ganesh Remedies | 1.01B |